In ER-positive tumors the intra-tumoral estrogen concentration can be 10-fold higher than the blood concentration of estrogens [38], and in most cases there is a gradient of aromatase expression towards the tumor in the affected breast (reviewed in [1]). The gene discussed is ESR1; the disease is neoplasm.